TADALAFIL

NDC 68788-4018 · Preferred Pharmaceuticals Inc.

Generic nameTADALAFIL

Dosage formTABLET

RouteORAL

Active ingredient(s)TADALAFIL

Strength5 mg/1

Pharmacologic classPhosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]

Marketing categoryANDA

Packages

68788-4018-1 — 15 TABLET in 1 BOTTLE (68788-4018-1)

68788-4018-2 — 20 TABLET in 1 BOTTLE (68788-4018-2)

68788-4018-3 — 30 TABLET in 1 BOTTLE (68788-4018-3)

FDA lists these products with the same active ingredient.

68071-3800 — tadalafil, 68071-3929 — Tadalafil, 68071-3936 — Tadalafil, 68071-5186 — Tadalafil, 68071-5202 — Tadalafil, 68180-914 — Tadalafil, 68382-896 — Tadalafil, 68382-897 — Tadalafil, 68382-898 — Tadalafil, 68382-899 — Tadalafil, 68788-4083 — tadalafil, 68788-8153 — Tadalafil, 68788-8292 — Tadalafil, 68788-8445 — Tadalafil, 68788-8465 — tadalafil, 68788-8664 — tadalafil, 69097-526 — Tadalafil, 69238-1346 — Tadalafil, 69238-1347 — Tadalafil, 69238-1348 — Tadalafil, +230 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.